Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro.
Krychtiuk KA, Kaun C, Hohensinner PJ, Stojkovic S, Seigner J, Kastl SP, Zuckermann A, Eppel W, Rauscher S, de Martin R, Maurer G, Huber K, Wojta J, Speidl WS.
Krychtiuk KA, et al. Among authors: hohensinner pj.
Vascul Pharmacol. 2017 Mar;90:44-50. doi: 10.1016/j.vph.2017.02.003. Epub 2017 Feb 10.
Vascul Pharmacol. 2017.
PMID: 28192257